Most recently, it's been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent places as classical opioid receptors, it binds into a wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions like a scavenger and doesn't activate